REILLY FINANCIAL ADVISORS, LLC - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 74 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$45,000
+2.3%
2,0000.0%0.00%0.0%
Q4 2020$44,000
+46.7%
2,0000.0%0.00%
+33.3%
Q3 2020$30,0000.0%2,0000.0%0.00%
-25.0%
Q2 2020$30,000
+36.4%
2,0000.0%0.00%
+33.3%
Q1 2020$22,000
+22.2%
2,0000.0%0.00%
+50.0%
Q4 2019$18,000
+20.0%
2,0000.0%0.00%0.0%
Q3 2019$15,000
-21.1%
2,0000.0%0.00%0.0%
Q2 2019$19,000
+72.7%
2,0000.0%0.00%
+100.0%
Q1 2019$11,000
+22.2%
2,0000.0%0.00%0.0%
Q4 2018$9,0002,0000.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 8,076$174,5220.01%
MASSMUTUAL TRUST CO FSB/ADV 46$9940.00%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders